• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS OPERATIONS, INC. COAGUCHEK XS PT TEST 2X24 STRIPS; TEST, TIME, PROTHROMBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS OPERATIONS, INC. COAGUCHEK XS PT TEST 2X24 STRIPS; TEST, TIME, PROTHROMBIN Back to Search Results
Model Number 04625315160
Device Problems Nonstandard Device (1420); High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/31/2019
Event Type  malfunction  
Event Description
Device used for coumadin blood level.Inr test strips showed extra high blood level of 3.8.(b)(6) recalls and lot no: 29415113 were listed that were used for this inr.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST 2X24 STRIPS
Type of Device
TEST, TIME, PROTHROMBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS OPERATIONS, INC.
MDR Report Key8670522
MDR Text Key147098143
Report NumberMW5087102
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 05/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2019
Device Model Number04625315160
Device Lot Number29415113
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/04/2019
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Treatment
PENICILLIN VK 500 MG; WARFARIN HYDROCHLORATHIAZIDE
Patient Age83 YR
-
-